American Journal Of Hematology SCIE

国际简称：AM J HEMATOL 参考译名：美国血液学杂志

主要研究方向：医学-血液学非预警期刊审稿周期：一般,3-6周

《美国血液学杂志》(American Journal Of Hematology)是一本由Wiley-Liss Inc.出版的以医学-血液学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
174 年发文量
10.1 IF影响因子
未开放 是否OA
92 H-index
1976 创刊年份
Monthly 出版周期
English 出版语言

The American Journal of Hematology provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease. The journal publishes original contributions in non-malignant and malignant hematological diseases including clinical and basic studies in hemostasis and thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports describing novel therapeutic approaches to diagnosis and treatment of hematological diseases are welcomed and encouraged. The journal includes regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, letters and correspondence.

[ 查看全部 ]

投稿咨询加急咨询

American Journal Of Hematology期刊信息

ISSN：0361-8609
出版语言：English
是否OA：未开放
E-ISSN：1096-8652
出版地区：UNITED STATES
是否预警：否
出版商：Wiley-Liss Inc.
出版周期：Monthly
创刊时间：1976
开源占比：0.1789
Gold OA文章占比：29.12%
OA被引用占比：0.1379...
出版国人文章占比：0.03
出版撤稿占比：0
研究类文章占比：89.66%

American Journal Of Hematology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

15.7

2.607

2.451

学科类别	分区	排名	百分位
大类：Medicine 小类：Hematology	Q1	9 / 137	93%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

American Journal Of Hematology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	2区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	2区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	2区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	2区

American Journal Of Hematology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：HEMATOLOGY	SCIE	Q1	8 / 97	92.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：HEMATOLOGY	SCIE	Q1	10 / 97	90.21%

American Journal Of Hematology历年数据统计

影响因子

中科院分区

American Journal Of Hematology中国学者发文选摘

1、Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia
Author: Wang, Qian; Cai, Wen-zhi; Wang, Qin-rong; Zhu, Ming-qing; Yan, Ling-zhi; Yu, Yan; Bao, Xie-bing; Shen, Hong-jie; Yao, Hong; Xie, Jun-dan; Zhang, Tong-tong; Zhang, Ling; Xu, Xiao-yu; Shan, Zhe; Liu, Hong; Cen, Jian-nong; Liu, Dan-dan; Pan, Jin-lan; Lu, Da-ru; Chen, Jia; Xu, Yang; Zhang, Ri; Wang, Ying; Xue, Sheng-li; Miao, Miao; Han, Yue; Tang, Xiao-wen; Qiu, Hui-ying; Sun, Ai-ning; Huang, Jin-yan; Dai, Hai-ping; Wu, De-pei; Chen, Su-ning

Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 1, pp. 66-78. DOI: 10.1002/ajh.26758
2、Proposed risk-scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma
Author: Yang, Peiyu; Chen, Haimin; Liang, Xinyue; Xu, Weiling; Yu, Shanshan; Huang, Wenyang; Yi, Xingcheng; Guo, Qiang; Tian, Mengru; Yue, Tingting; Li, Mengyao; Zhang, Yingjie; Zhang, Mengxue; Yan, Yurong; Hu, Zhongli; Kumar, Shaji K.; Zhou, Fan; Dai, Yun; Jin, Fengyan

Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 2, pp. 251-263. DOI: 10.1002/ajh.26774
3、Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate-risk acute myeloid leukemia in first complete remission undergoing auto-HSCT: An open-label, multicenter, randomized phase 3 trial
Author: Liu, Hui; Huang, Fen; Zhang, Yu; Wu, Meiqing; Xu, Na; Fan, Zhiping; Sun, Zhiqiang; Li, Xudong; Lin, Dongjun; Xiong, Yiying; Liu, Xiaodan; Lin, Ren; Shi, Pengcheng; Xu, Jun; Wang, Zhixiang; Li, Xiaofang; Sun, Jing; Liu, Qifa; Xuan, Li

Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 3, pp. 408-412. DOI: 10.1002/ajh.26800
4、The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases
Author: Cao, Yigeng; Gong, Xiaowen; Feng, Yahui; Wang, Mingyang; Hu, Yu; Liu, Huilan; Liu, Xueou; Qi, Saibing; Ji, Yanping; Liu, Fang; Zhu, Huaiping; Guo, Wenwen; Shen, Qiujin; Zhang, Rongli; Zhao, Ningning; Zhai, Weihua; Song, Xiaoqiang; Chen, Xin; Geng, Liangquan; Zheng, Xuetong; Ma, Qiaoling; Tang, Baolin; Wei, Jialin; Huang, Yong; Ren, Yuanyuan; Song, Kaidi; Yang, Donglin; Pang, Aiming; Yao, Wen; He, Yi; Shang, Yue; Wan, Xiang; Zhang, Wei; Zhang, Song; Sun, Guangyu; Feng, Sizhou; Zhu, Xiaofan; Han, Mingzhe; Song, Zhen; Guo, Ye; Sun, Zimin; Jiang, Erlie; Chen, Junren

Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 2, pp. 309-321. DOI: 10.1002/ajh.26792
5、Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study
Author: Cui, Lei; Wang, Chan-Juan; Lian, Hong-Yun; Zhang, Li; Ma, Hong-Hao; Wang, Dong; Chen, Fen-Fen; Zhang, Qing; Yang, Ying; Wei, Ang; Huang, Xiao-Tong; Zhu, Ting; Wang, Tian-You; Li, Zhi-Gang; Zhang, Rui

Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 4, pp. 598-607. DOI: 10.1002/ajh.26829
6、Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study
Author: Xu, Wei; Zhou, Keshu; Wang, Tingyu; Yang, Shenmiao; Liu, Lihong; Hu, Yu; Zhang, Wei; Ding, Kaiyang; Zhou, Jianfeng; Gao, Sujun; Xu, Bing; Zhu, Zunmin; Liu, Ting; Zhang, Huilai; Hu, Jianda; Ji, Chunyan; Wang, Shunqing; Xia, Zhongjun; Wang, Xin; Li, Yan; Song, Yongping; Ma, Shuo; Tang, Xinran; Zhang, Bin; Li, Jianyong

Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. 98, Issue 4, pp. 571-579. DOI: 10.1002/ajh.26826
7、Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD-ALL-2008): An open-label, multicentre, randomized, phase III clinical trial
Author: Qiu, Kun-yin; Wang, Jia-yi; Huang, Li-bin; Li, Chang-gang; Xu, Lu-hong; Liu, Ri-yang; Chen, Hui-qin; Ruan, Yong-sheng; Zhen, Zi-jun; Li, Chi-kong; Fang, Jian-pei

Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ajh.26910
8、Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation
Author: Tang, Yaqiong; Zhang, Ziyan; Liu, Silu; Yao, Yifang; Pan, Tingting; Qi, Jiaqian; Kang, Huizhu; Liu, Yuejun; Cai, Chengsen; Zhou, Meng; He, Xuefeng; Hu, Xiaohui; Ma, Xiao; Wu, Depei; Han, Yue

Journal: AMERICAN JOURNAL OF HEMATOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ajh.26903